Lymphoma Non-Hodgkin's, Adult: Difference between revisions
From OncoWiki
Jump to navigationJump to search
Line 74: | Line 74: | ||
[[Bonn protocol]]<br> | [[Bonn protocol]]<br> | ||
[[RTOG study 93-10]] (deAngelis regime)<br> | [[RTOG study 93-10]] (deAngelis regime)<br> | ||
[[R-MPV]] | [[R-MPV]]<br> | ||
[[Temozolomide]] | [[Temozolomide]] | ||
== External Links == | == External Links == | ||
[http://www.cancer.gov/cancertopics/pdq/treatment/adult-non-hodgkins/healthprofessional Cancernet PDQ] | [http://www.cancer.gov/cancertopics/pdq/treatment/adult-non-hodgkins/healthprofessional Cancernet PDQ] |
Latest revision as of 21:45, 16 May 2016
Regimens
Indolent NHL
- Bendamustine
- Chlorambucil
- Cyclophosphamide
- Fludarabine
- Rituximab
- Rituximab, Bendamustine, Bortezomib
- CVP
- R-CVP
- FC
- FCM
- R-FCM
- FN
- FND
- MCP
- R-MCP
- RC
Aggressive NHL
B Cell
CHOP
R-CHOP
CHOP-14
CHOEP-14
CEOP
CNOP
COPP
DHAP
DHAX
EPIC
EPOCH
EPOCH-DA
R-EPOCH
ESHAP
GEM-P
GEM-Vinorelbine-Pred
HyperCVAD
ICE
RICE
IMVP-16
MACOP-B
VNCOP-B
MIME
MINE/ESHAP
m-BACOD
MiCMA
T Cell
Mantle Cell Lymphoma
Bendamustine
R-CHOP
R-FCM
R-FCM + maintenance R
Bortezomib
R-GemOx
HyperCVAD
Pre-B or T lymphoblastic lymphoma
Burkitt's Lymphoma
- BFM B-Cell (German protocol)
- CODOX-M/IVAC
- Modified CODOX-M
- CALGB 9251
Primary CNS Lymphoma
High dose Methotrexate
Bonn protocol
RTOG study 93-10 (deAngelis regime)
R-MPV
Temozolomide